14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Ambient Air Pollution and Type 2 Diabetes: Do the Metabolic Effects of Air Pollution Start Early in Life?

      article-commentary
      Diabetes
      American Diabetes Association

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The adverse health effects of ambient (outdoor) air pollution have been recognized since increased mortality due to smog was reported in London in 1952 (1). Suspended particles (particulate matters) from soot were associated with increased mortality and morbidity related to both respiratory and cardiovascular disorders (1). Since then, great efforts have been made to control ambient air pollution on a national level. For example, the Clean Air Act in the U.S. resulted in improvements in ambient air quality. Between 1990 and 2015, annual concentrations of particulate matter <10 µm in aerodynamic diameter (PM10) dropped by 39% in the U.S. (2). Nonetheless, ambient air pollution is still one of the leading causes of global disease burden (3,4). In fact, the World Health Organization has estimated that ambient air pollution is responsible for more than 3 million deaths, representing 5.4% of total deaths in 2012 (5). Recently, scientific communities have suggested that ambient air pollution may increase the risk of type 2 diabetes. Animal models have provided convincing evidence and suggested potential mechanisms including particle-mediated alterations in glucose homeostasis, inflammation in visceral adipose tissue, endoplasmic reticulum stress in liver and lung, mitochondrial dysfunction and brown adipose tissue dysfunction, inflammation mediated through Toll-like receptors and nucleotide-binding oligomerization domain-like receptors, and inflammatory signaling in key regions of the hypothalamus (6). Although the evidence is still limited, epidemiological studies have also supported the hypothesis that ambient air pollution exposure is associated with elevated risk for type 2 diabetes (7–9). Important questions not fully addressed by the literature include the following: 1) what are the potential mechanisms supported by human population data? and 2) when do the adverse metabolic effects of ambient air pollution start? In this issue of Diabetes, Alderete et al. (10) address these questions by evaluating the associations between long-term ambient air pollution exposure and longitudinal measures of insulin resistance, β-cell functions, and adiposity in 314 overweight and obese Latino children aged 8 to 15 years at baseline in Los Angeles, California. This study evaluated two air pollutants: nitrogen dioxide (NO2), a measure of traffic-related exposure, and PM2.5, an indicator of both traffic-related and regionally transported particles. Long-term exposure to these air pollutants were computed as yearly concentrations averaged over an individual’s follow-up. This study is unique in that direct measures of glucose homeostasis based on the frequently sampled intravenous glucose tolerance test were used rather than indirect estimates from fasting glucose and insulin (i.e., HOMA of insulin resistance). In addition, the measures were longitudinally assessed for an average of 3.4 years with an average of four repeated measurements, allowing the investigators to evaluate whether higher exposure to ambient air pollution accelerates impairments in insulin sensitivity and β-cell function. The authors report that higher exposure to both NO2 and PM2.5 were statistically significantly associated with a faster decline in the whole-body insulin sensitivity measure. NO2, but not PM2.5, was statistically significantly associated with a faster decline in the disposition index, an indicator of β-cell function. These associations were observed after adjustment for important confounding factors such as social position and body fat percent, suggesting that the observed associations are independent of socioeconomic status and adiposity, although residual confounding by built environment and residential noise could not be ruled out (11,12). In addition, both NO2 and PM2.5 were statistically significantly associated with faster increases in BMI and subcutaneous abdominal adipose tissue. This study failed to show that either NO2 or PM2.5 was statistically significantly associated with visceral fat increments, a potential mechanism supported by animal studies (13,14). Traditionally, visceral fat has been considered a major contributing factor for insulin resistance, but a growing body of evidence suggests that abdominal subcutaneous fat may also play a critical role in the development of insulin resistance (15). These findings shed light on potential mechanisms by which ambient air pollution exposure, especially traffic-related pollution, influences type 2 diabetes risk. Long-term air pollution exposure may 1) diminish insulin-dependent glucose uptake, leading to insulin resistance; 2) impair β-cell function, resulting in reduced insulin secretion; and 3) promote subcutaneous fat accumulation. Upstream pathways linking air pollution exposure and insulin resistance, β-cell dysfunction, and adiposity suggested by animal studies (e.g., oxidative stress, systemic inflammation, inhibition of insulin signaling, adipose tissue inflammation) remain to be elucidated in humans. The observed findings in overweight and obese children raise the question of whether ambient air pollution is sufficient to disrupt glucose homeostasis or if it worsens glucose homeostasis only in metabolically predisposed individuals. Two population-based studies conducted in children 10–15 years of age in German birth cohorts reported a significant positive association between NO2 and insulin resistance (16,17). This association remained significant even after adjustment for green spaces such as natural vegetation, parks, and gardens (17). This finding suggests that traffic-related exposure is at least a sufficient cause of insulin resistance. More studies are warranted to confirm whether adiposity confers susceptibility to air pollution exposure–related β-cell dysfunction. The study by Alderete et al. (10) suggests childhood exposure to ambient air pollution between the ages of 10 and 18 may be responsible for rapid metabolic dysfunction. How important is early air pollution exposure? Because residential history was not available, this study could not evaluate or account for earlier exposure in childhood or prenatal exposure. A birth cohort study conducted in the Bronx and Northern Manhattan, New York, reported that higher maternal exposure to ambient polycyclic aromatic hydrocarbons (chemicals created during incomplete combustion processes) during pregnancy was associated with higher risk for obesity at 7 years of age (18). This finding was replicated in another prospective birth cohort study in Massachusetts, Project Viva, which showed that prenatal exposure to traffic-related pollution was associated with more rapid postnatal weight gain and higher midchildhood cardiometabolic risk including total fat mass and leptin concentrations (19,20). Together, these data and those from the study by Alderete et al. suggest that there is no specific window of susceptibility to the metabolic effects of air pollution during childhood. Traffic-related pollution may be a previously unrecognized contributor to the epidemic of pediatric obesity and related metabolic conditions in the U.S. In summary, the findings of Alderete et al. (10) suggest that current urban air quality in the U.S. may not be safe enough for overweight and obese children who are vulnerable to cardiometabolic diseases later in life. If this is true, changes in diet and physical activity at the individual level may be insufficient to prevent obesity and type 2 diabetes in children and adolescents. This study and other recent work provide important scientific evidence that population-wide policies enforcing or even tightening national ambient air quality standards by the U.S. Environmental Protection Agency are critical to protect our next generation.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Air Pollution and Type 2 Diabetes

          Epidemic of Cardiometabolic Disease in Developing Nations: A Threat to Global Prosperity According to the International Diabetes Federation in the year 2011, diabetes mellitus (DM) affects at least 366 million people worldwide, and that number is expected to reach 566 million by the year 2030. Over 99% of all diabetes cases represent type 2 DM with most of these projected to occur in low- to middle-income countries. Technology innovations, globalization with its free movement of food and services, seismic shifts in agrarian practices, and nutritional transition to freely available high-caloric diets have irrevocably altered energy expenditures during work and leisure. These and other factors are helping to foster the continued epidemiological transition occurring across the globe. Scientific effort over the last few decades has focused primarily on components of urbanization such as inactivity and dietary factors. More recent observations have provided additional links between exposure to environmental factors in air/water and propensity to chronic diseases (1). This issue is of importance given the extraordinary confluence of high levels of airborne and water pollutants in urbanized environments. Multiple studies in China, India, and other rapidly urbanizing economies demonstrate a steep gradient in urban–rural prevalence. This review will summarize recent evidence on how outdoor air pollution may represent an underappreciated yet critical linkage between urbanization and the emergence of cardiometabolic diseases, with a focus on type 2 DM. We define cardiometabolic disease as the confluence of cardiovascular disease and type 2 DM in recognition of the fact that the milieu of diabetes fundamentally alters the pathophysiology of coronary, cerebrovascular, and peripheral arterial disease. Thus, alteration in susceptibility to DM automatically increases the likelihood of cardiovascular disease. Indoor air pollution is not discussed owing to the paucity of data. It should be noted that our current understanding of air pollution–mediated cardiometabolic disease is derived from outdoor air pollution studies, with there being no good reasons to believe that the dose-response relationship to indoor air pollution will be any different. An understanding of potentially reversible environmental factors responsible for this rapid burgeoning of cardiometabolic disorders among developing nations is crucial in order to devise a societal response that is proportionate and adequate (2). In this review, the association between air pollution and type 2 DM is discussed unless this distinction cannot be made in the cited study (typically health registry data sets). Exposure to Environmental Toxins and Metabolic Disease Epidemiologic studies that have attempted to investigate environmental factors that accentuate risk for development of cardiometabolic disorders have uncovered a number of factors other than traditional suspects related to diet and exercise. These variables include factors such as stress (mental and emotional), cultural and socioeconomic variables, chronic low-grade infection, and environmental pollutants (Fig. 1). In many instances, these factors are strongly correlated, rendering isolation of cause and effect difficult. FIG. 1. A model for development of cardiometabolic disease highlighting importance of gene–environment interactions. (A high-quality digital representation of this figure is available in the online issue.) The plausibility that environmental exposures are linked to metabolic disease is exemplified by persistent organic pollutants, toxins that have consistently shown to associate with insulin resistance (IR) and type 2 DM. Prospective cohort studies of subjects exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin or other persistent organic pollutants in occupational and other settings have reported increased risk of DM and IR (1,3). Air pollution in Asia, Latin America, and Africa is a significant public health burden, especially given the often extraordinarily high concentrations of pollutants (e.g., particulate matter), high population density, and pervasive nature of air pollution. Table 1 lists the top countries for particulate matter (PM) air pollution in the world, all of which have rapidly urbanized populations based on a World Health Organization (WHO) database that reviewed pollution data in >1,100 cities in 91 countries. The mean annual average for the top 10 countries is roughly fivefold higher than the U.S. National Ambient Air Quality Standard of 15 μg/m3 for PM 176 ng/mL associated with a fourfold excess risk. Addition to SP-D levels to traditional risk factors improved c-statistic (from 0.76 to 0.78) and net reclassification across all levels of risk (52). In the Dallas Heart Study, increasing levels of SP-B was associated with other traditional cardiac risk factors and higher levels of inflammatory biomarkers. In multivariable analyses after adjusting for risk factors, SP-B remained associated with aortic plaque in smokers (odds ratio 1.87, fourth versus first quartiles; P < 0.0001) (53). How does one reconcile increases in plasma SP levels in population studies to increase susceptibility? Increased levels of surfactants in plasma seen in smoking and lung inflammation have been hypothesized to indicate translocation from the lung to the circulation with lung damage. Surfactants A and D are assembled as large multimeric units composed of lectin-containing globular domains and a collagenous domain. In the presence of DAMPs, they may exert proinflammatory effects by binding to CD47 (thrombospondin receptor) (48). It is also highly possible that increased levels may indicate oxidatively modified forms of surfactant that are not functional. Surfactants are often assembled as multimers and are well-known to undergo oxidative modification to oligomeric forms. Current assays for SPs do not distinguish between these various forms. Future Directions A growing body of evidence has implicated inflammatory responses to diet and environmental factors as a key mechanism that help explain the emerging epidemic in diabetes and cardiovascular disease. Both genetic and environmental factors undoubtedly play a role, although the role of the physical and social environment in determining susceptibility appears to be critical. Nontraditional factors such as air pollution that are pervasive in the urban environment may provide low-level synergism with other dominant factors in accelerating propensity for type 2 DM. Emerging data from both experimental and epidemiologic studies are beginning to provide insights into this association. There are a number of areas that would benefit from further studies and enable additional insights into the mechanisms by which environmental signals modulate susceptibility to metabolic disease. The effects of air-pollution exposure on β-cell function, counterregulatory hormones such as glucagon, and effects on insulinotropic mechanisms deserve further study. The effects of air pollution on hypothalamic mechanisms of appetite and satiety are areas of emerging interest, as it is entirely possible that air pollutants may modulate inflammation in key brain homeostatic centers. In addition, the effects on central autonomic control of peripheral inflammation may represent additional pathways by which environmental triggers may play an important role in determining peripheral inflammation. The societal costs of this link, if indeed true, are staggering given the ubiquitous nature of air pollution and the economic costs of obesity/DM-related complications. Given the already established nature of the links between air pollution and cardiovascular disease and regulations already in place, at least in countries like the U.S. and Europe, these additional links, if they can be established in additional large cohorts, would provide persuasive rationale for limiting exposure to air pollution.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Body Fat Distribution and Insulin Resistance

            The burden of obesity has increased globally over the last few decades and its association with insulin resistance and related cardio-metabolic problems have adversely affected our ability to reduce population morbidity and mortality. Traditionally, adipose tissue in the visceral fat depot has been considered a major culprit in the development of insulin resistance. However, there is a growing body of evidence supporting the role of subcutaneous truncal/abdominal adipose tissue in the development of insulin resistance. There are significant differences in the functional characteristics of subcutaneous abdominal/truncal vs. intraabdominal vs. gluteo-femoral fat depots. More recently, mounting evidence has been supporting the role of adipose tissue function in the development of metabolic complications independent of adipose tissue volume or distribution. Decreased capacity for adipocyte differentiation and angiogenesis along with adipocyte hypertrophy can trigger a vicious cycle of inflammation leading to subcutaneous adipose tissue dysfunction and ectopic fat deposition. Therapeutic lifestyle change continues to be the most important intervention in clinical practice to improve adipose tissue function and avoid development of insulin resistance and related cardio-metabolic complications.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effect of early particulate air pollution exposure on obesity in mice: role of p47phox.

              To evaluate the role of early-life exposure to airborne fine particulate matter (diameter, <2.5 μm [PM(2.5)]) pollution on metabolic parameters, inflammation, and adiposity; and to investigate the involvement of oxidative stress pathways in the development of metabolic abnormalities. PM(2.5) inhalation exposure (6 h/d, 5 d/wk) was performed in C57BL/6 mice (wild type) and mice deficient in the cytosolic subunit of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase p47(phox) (p47(phox-/-)) beginning at the age of 3 weeks for a duration of 10 weeks. Both groups were simultaneously fed a normal diet or a high-fat diet for 10 weeks. PM(2.5)-exposed C57BL/6 mice fed a normal diet exhibited metabolic abnormalities after exposure to PM(2.5) or FA for 10 weeks. Consistent with insulin resistance, these abnormalities included enlarged subcutaneous and visceral fat contents, increased macrophage infiltration in visceral adipose tissue, and vascular dysfunction. Ex vivo-labeled and infused monocytes demonstrated increased adherence in the microcirculation of normal diet- or high-fat diet-fed PM(2.5)-exposed mice. p47(phox-/-) mice exhibited an improvement in parameters of insulin resistance, vascular function, and visceral inflammation in response to PM(2.5). Early-life exposure to high levels of PM(2.5) is a risk factor for subsequent development of insulin resistance, adiposity, and inflammation. Reactive oxygen species generation by NADPH oxidase appears to mediate this risk.
                Bookmark

                Author and article information

                Journal
                Diabetes
                Diabetes
                diabetes
                diabetes
                Diabetes
                Diabetes
                American Diabetes Association
                0012-1797
                1939-327X
                July 2017
                15 June 2017
                : 66
                : 7
                : 1755-1757
                Affiliations
                [1]Departments of Epidemiology and Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, MI
                Author notes
                Corresponding author: Sung Kyun Park, sungkyun@ 123456umich.edu .
                Article
                0012
                10.2337/dbi17-0012
                5482079
                28637828
                f27bbbf1-30be-4a51-b58e-83fbf335df92
                © 2017 by the American Diabetes Association.

                Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

                History
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 20, Pages: 3
                Funding
                Funded by: National Institute of Environmental Health Sciences, DOI http://dx.doi.org/10.13039/100000066;
                Award ID: R01-ES026578
                Award ID: R01-ES026964
                Award ID: P30-ES017885
                Funded by: National Institute for Occupational Safety and Health, DOI http://dx.doi.org/10.13039/100000125;
                Award ID: T42-OH008455
                Categories
                Commentary

                Endocrinology & Diabetes
                Endocrinology & Diabetes

                Comments

                Comment on this article